Clinical Trial Update: Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating early administration of insulin glargine in patients with diabetic ketoacidosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Ketoacidosis

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: HealthPartners Institute | Conditions: DKA | Phase 2 | Status: TERMINATED